Sudeep Pharma Ltd

NSE: SUDEEPPHRM · BSE: 544619 · Pharmaceuticals & Biotechnology · 20 announcements

Share price: ₹1,175.00
Market cap: ₹13,271 Cr
Revenue (annual): ₹642.3 Cr
Net profit (annual): ₹172.9 Cr
P/E (TTM): 72.7×Sector 47.4×
Promoter holding: 76.15%+0.00% QoQ
FII holding: 1.81%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Dividend 3 Other Announcement 2 Board Meeting Date 2 Annual General Meeting 2 Management Change 1 Capital Structure Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Aug 2026 17:59 IST NSE

Financial Results

Sudeep Pharma Q1 FY27 Results: Net Profit ₹40.6 Cr, Up 29.7% YoY

Sudeep Pharma Ltd reported revenue from operations of ₹158.3 Cr (+26.7% YoY) and net profit of ₹40.6 Cr (+29.7% YoY) for Q1 FY27.

Key figure: Net profit ₹40.6 Cr · +29.7% YoY

Open full results → Read the filing ↗

21 May 2026 16:06 IST BSE

Financial Results

Sudeep Pharma Q4 FY26 Results: Net Profit ₹48.5 Cr, Up 9.7% YoY

Sudeep Pharma Ltd reported revenue from operations of ₹182.3 Cr (+15.7% YoY) and net profit of ₹48.5 Cr (+9.7% YoY) for Q4 FY26.

Key figure: Net profit ₹48.5 Cr · +9.7% YoY

Open full results → Read the filing ↗

21 May 2026 16:05 IST BSE

Financial Results

Sudeep Pharma Financial Results

Sudeep Pharma reported a consolidated annual net profit of ₹174.28 Crore for FY2026. The board also recommended a final dividend of ₹1.50 per equity share.

Value: ₹174.3 Cr

Read the filing ↗